Axsome Therapeutics (AXSM) Misses Q3 EPS by 10c
Tweet
Share
E-mailGet Alerts AXSM Hot Sheet
Join SI Premium – FREE
Axsome Therapeutics (NASDAQ: AXSM) reported Q3 EPS of ($0.95), $0.10 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $171 million versus the consensus estimate of $162.45 million.
For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- S&P Global (SPGI) Declares $0.97 Quarterly Dividend; 1% Yield
- A. O. Smith CEO Stephen Shafer named chairman
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
